SA
SAVA
FILANA THERAPEUTICS, INC.
$24.68 ▼ -0.72%
Prev close $24.8612-mo target$8.00 (+236.1%)
Biotech & Drug Discovery
Price chart 30d +0.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Mar 3, 2026 earnings_calendar
SAVA Q4 2025 Earnings After Market Close — 2026-03-03
Analyst ratings
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Oct 6, 2025 | LUCID CAPITAL MARKETS | INITIATE | Buy | 36% |
| Mar 25, 2025 | HC Wainwright & Co. | REITERATE | Neutral | 43% |
| Mar 4, 2025 | HC Wainwright & Co. | REITERATE | Neutral | 43% |
| Nov 26, 2024 | HC Wainwright & Co. | DOWNGRADE | Neutral | 43% |
| Nov 8, 2024 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Oct 8, 2024 | HC Wainwright & Co. | UPGRADE | Buy | 43% |
| Aug 13, 2024 | HC Wainwright & Co. | REITERATE | Neutral | 43% |
| Aug 8, 2024 | Rodman & Renshaw | REITERATE | Buy | 39% |
| Jul 19, 2024 | HC Wainwright & Co. | REITERATE | Neutral | 43% |
| Jul 1, 2024 | Jones Trading | DOWNGRADE | Hold | 51% |
Price targets
Where 1 covering analysts think SAVA trades over the next 12 months.
$8.00 +236.1% upside Strong Buy
Current$2.38 Low$8.00 Median$8.00 High$8.00 1 analysts
$8.00$8.00
Analyst rating None as of May 12, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Mar 3, 2026
earnings_calendar
SAVA Q4 2025 Earnings After Market Close — 2026-03-03
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Next Q | $-0.31 | $-0.31–$-0.31 | — | -3.3% | — | $0.0B | 1 |
| Current FY | $-1.93 | $-1.93–$-1.93 | -264.2% | +0.0% | 1↑ 0↓ | $0.0B | 1 |
| Current Q | $-0.30 | $-0.30–$-0.30 | 47.4% | -11.1% | — | $0.0B | 1 |
| Next FY | $-1.22 | $-1.22–$-1.22 | 36.8% | -5.2% | 1↑ 0↓ | $0.0B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.300 | — |
| 7d ago | $-0.270 | -0.030 |
| 30d ago | $-0.270 | -0.030 |
| 60d ago | $0.000 | -0.300 |
| 90d ago | $0.000 | -0.300 |